Akio Maki

430 total citations
25 papers, 352 citations indexed

About

Akio Maki is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Akio Maki has authored 25 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Akio Maki's work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Neurobiology and Insect Physiology Research (3 papers). Akio Maki is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Neurobiology and Insect Physiology Research (3 papers). Akio Maki collaborates with scholars based in Japan, Switzerland and Germany. Akio Maki's co-authors include Shigeaki Kato, Ken‐ichi Takeyama, Saya Ito, Shun Sawatsubashi, Eriko Suzuki, Alexander Kouzmenko, Tetsu Akiyama, Takashi Furutani, Yoshihiro Kawasaki and Kaoru Yamagata and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Biochemical and Biophysical Research Communications.

In The Last Decade

Akio Maki

21 papers receiving 344 citations

Peers

Akio Maki
Silvia Pulido United States
Jeong Soo Hong South Korea
Ko–ichiro Yoshiura Japan
Ping Ye United States
Valérie Schaeffer United States
Christine C. Quirk United States
Debnath Mukhopadhyay United States
Yangjian Liu United States
Kay Rasmussen United States
R. Paniagua Spain
Silvia Pulido United States
Akio Maki
Citations per year, relative to Akio Maki Akio Maki (= 1×) peers Silvia Pulido

Countries citing papers authored by Akio Maki

Since Specialization
Citations

This map shows the geographic impact of Akio Maki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akio Maki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akio Maki more than expected).

Fields of papers citing papers by Akio Maki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akio Maki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akio Maki. The network helps show where Akio Maki may publish in the future.

Co-authorship network of co-authors of Akio Maki

This figure shows the co-authorship network connecting the top 25 collaborators of Akio Maki. A scholar is included among the top collaborators of Akio Maki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akio Maki. Akio Maki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shiratori, Souichi, Kentaro Fukushima, Yasushi Onishi, et al.. (2024). Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study. International Journal of Hematology. 120(6). 705–716.
2.
Teshima, Takanori, Yasushi Onishi, Koji Kato, et al.. (2024). Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial. International Journal of Hematology. 120(1). 106–116. 1 indexed citations
3.
Minami, Yosuke, Noriko Doki, Hiroshi Matsuoka, et al.. (2024). Asciminib in Patients With CML-CP Previously Treated With ≥ 2 Tyrosine Kinase Inhibitors: 96-Week Results From the Japanese Subgroup Analysis of the ASCEMBL Study. International Journal of Hematology. 120(3). 305–313. 1 indexed citations
4.
5.
Nakamae, Hirohisa, Masahide Yamamoto, Emiko Sakaida, et al.. (2021). Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial. International Journal of Hematology. 115(1). 33–42. 8 indexed citations
6.
7.
Sato, Naoki, Wataru Takahashi, Atsushi Hirayama, et al.. (2015). LATE BREAKING CLINICAL TRIAL (JCS 2015) : Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure. Circulation. 79(6). 1237–1247. 10 indexed citations
8.
Sato, Naoki, Wataru Takahashi, Atsushi Hirayama, et al.. (2015). Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure. Circulation Journal. 79(6). 1237–1247. 18 indexed citations
9.
Sawatsubashi, Shun, Akio Maki, Saya Ito, et al.. (2004). Ecdysone receptor-dependent gene regulation mediates histone poly(ADP-ribosyl)ation. Biochemical and Biophysical Research Communications. 320(1). 268–272. 17 indexed citations
10.
Takeyama, Ken‐ichi, Saya Ito, Shun Sawatsubashi, et al.. (2004). A Novel Genetic System for Analysis of Co-activators for the N-Terminal Transactivation Function Domain of the Human Androgen Receptor. Bioscience Biotechnology and Biochemistry. 68(6). 1209–1215. 4 indexed citations
11.
Maki, Akio, Shun Sawatsubashi, Saya Ito, et al.. (2004). Juvenile hormones antagonize ecdysone actions through co-repressor recruitment to EcR/USP heterodimers. Biochemical and Biophysical Research Communications. 320(1). 262–267. 53 indexed citations
12.
Kouzmenko, Alexander, Ken‐ichi Takeyama, Saya Ito, et al.. (2004). Wnt/β-Catenin and Estrogen Signaling Converge in Vivo. Journal of Biological Chemistry. 279(39). 40255–40258. 180 indexed citations
13.
Shirai, Masafumi, Akio Maki, Noboru Yanaihara, et al.. (1990). Content and distribution of vasoactive intestinal polypeptide (VIP) in cavernous tissue of human penis. Urology. 35(4). 360–363. 17 indexed citations
14.
Kumamoto, Y, Y Yamaguchi, Yoshiaki Sato, et al.. (1990). [Effects of anti-androgens on sexual function. Double-blind comparative studies on allylestrenol and chlormadinone acetate. Part II: Self-assessment questionnaire method].. PubMed. 36(2). 227–44. 4 indexed citations
15.
Maki, Akio, et al.. (1988). Primary lipogranuloma of male genitalia. Urology. 31(1). 75–77. 5 indexed citations
16.
Maki, Akio, et al.. (1988). Orf: contagious pustular dermatitis.. PubMed. 139(10). 971–2. 7 indexed citations
17.
Maki, Akio, et al.. (1983). STUDIES ON MALE SEXUAL IMPOTENCE. The Japanese Journal of Urology. 74(7). 1219–1227. 1 indexed citations
18.
Maki, Akio, et al.. (1983). STUDIES ON MALE SEXUAL IMPOTENCE REPORT XIV. The Japanese Journal of Urology. 74(8). 1423–1428. 1 indexed citations
19.
Tomida, Masayuki, et al.. (1968). The effect of plant hormones on the multiplication of plant viruses. Annual Report of The Kansai Plant Protection Society. 10(0). 35–39. 1 indexed citations
20.
Maki, Akio, et al.. (1963). The Synthesis of Depsidones. I. YAKUGAKU ZASSHI. 83(12). 1172–1174. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Pulido Breakdown of academic impact, for papers by Jeong Soo Hong Breakdown of academic impact, for papers by Ko–ichiro Yoshiura Breakdown of academic impact, for papers by Ping Ye Breakdown of academic impact, for papers by Valérie Schaeffer Breakdown of academic impact, for papers by Christine C. Quirk Breakdown of academic impact, for papers by Debnath Mukhopadhyay Breakdown of academic impact, for papers by Yangjian Liu Breakdown of academic impact, for papers by Kay Rasmussen Breakdown of academic impact, for papers by R. Paniagua
Rankless by CCL
2026